Sainz-Calvo, Álvaro Jesús
Sierra-Padilla, Alfonso
Bellido-Milla, Dolores
Blanco-Díaz, Lorena
Fernández-Alba, Juan Jesús
González-Macías, Carmen
García-Guzmán, Juan José
Palacios-Santander, José María
Cubillana-Aguilera, Laura
Funding for this research was provided by:
Universidad de Cadiz
Article History
Received: 22 October 2025
Accepted: 6 December 2025
First Online: 27 December 2025
Declarations
:
: All the studies implying research work applied to biological samples (human blood, plasma, and/or serum) were conducted in accordance with the Declaration of Helsinki, and the aforementioned projects and, consequently, the present study, in accordance with the Spanish regulation ‘Real Decreto 1090/2015, de 4 de diciembre, por el que se regulan los ensayos clínicos con medicamentos, los Comités de Ética de la Investigación con medicamentos y el Registro Español de Estudios Clínicos’, was approved by the Research Ethics Committee of Cadiz (Spain), on May 12, 2023, registry/protocol number 15.23. The resolution stated that the aforementioned projects, involving human samples, are viable, that they present sufficient methodological rigor, that the evaluation of economic costs are correct, and that with respect to the ethical aspects, the projects meet the necessary requirements of suitability of the protocol in relation to the objectives of the study.
: Not applicable.
: The authors declare no competing interests.